Saving Lives with Naloxone-A focus on Opioid Harm Reduction
Description Heading link
Background:
In August 2019, the State of Illinois passed Public Act 101-0278, requiring the establishment of an evidence-based, non-commercial education program for Medicaid prescribers consisting of a web-based curriculum and academic educator outreach. As a result of this legislation, the Illinois Department of Healthcare and Family Services is partnering with the University of Illinois at Chicago College of Pharmacy to provide drug information and academic detailing services through Illinois ADVANCE.
What is academic detailing:
Academic detailing is a one-on-one prescriber outreach program. It provides accurate, non-commercial, and up-to-date pharmacotherapy information. It is a unique interactive program tailored for each prescriber through customized and focused discussions. The educational materials provided during these visits are developed after a careful review of current clinical evidence.
How to participate and obtain CE:
Sign up for a 0.5 hour academic detailing session on one or more of the available CE topics at https://illinoisadvance.com/contact-academic-detailing/.
You will meet with a clinical pharmacist for a brief academic detailing visit. Upon completion of the session, you will complete a post-assessment and submit an activity evaluation survey. Your CE credit will then be uploaded to CPE Monitor.
For more information about the CEs or the CE topics, contact illinoisadvance@uic.edu.
Disclosures Heading link
Pharmacist Academic Detailer Speaker:
Please visit https://illinoisadvance.com/about-us/meet-team/ for a list of potential speakers.
Disclosure (s):
The speakers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.
- Speaker, Dr. Chintan Patel has stock ownership with companies: Abbvie, Dynavax Technologies Corp, Esperion Therapeutics Inc, Gilead Sciences Inc, Glasko Smith Kline, Haleon, EOM Pharmaceuticals, Lisata Therapeutics Inc, Novavax Inc, Pfizer Inc, Protalix Biotherapeutics Inc, and PuImatrix Inc.
- Speaker, Dr. Thomas Dorn has stock ownership with companies Inovio Pharmaceuticals, Eli Lily, and Lexicon Pharmaceuticals.
- Speaker, Dr. Sajitha Purathur has stock ownership with Pfizer.
- Speaker, Dr. Chirag Rathod has stock ownership with MindMed.
- Speaker, Dr. Stewart Chung has stock ownership with Silo Pharmaceutical.
All relevant financial relationships listed for the above speakers have been mitigated.
Learning Objectives Heading link
Type of Activity: Knowledge-based
Learning Objectives:
- Describe the role of naloxone co-prescribing in reducing opioid-related fatal overdose
- Explain the factors that can affect acceptance and use of naloxone
Activity Information Heading link
| Target Audience: | Pharmacists | Fee: | Free |
| Release Date: | March 7, 2024 | Expiration Date: | March 7, 2026 |
| Estimated Time to Complete: | 0.5 hours | CE: | 0.5 contact hours (0.05 CEUs) |
Go to activity
Credit Heading link
How to Earn Credit:
Participants must complete the activity as described in the Continuing Education Statement by attending the entire academic detailing session, completing a post-test, and successfully submitting an activity evaluation. The uploading of CPE credits to CPE Monitor will be issued after all requirements as described are completed.
CE statement Heading link
Continuing Education Statement:
The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned ACPE Universal Activity Number 0016-0000-24-032-H08-P, for 0.5 contact hours (0.05 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test, and activity evaluation; estimating the duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.
Addtl info Heading link
Hardware/Software and Internet Requirements can be found at https://ce.pharmacy.uic.edu/online-activities/requirements/.
Provider Contact Information:
For information about IL Advance, your academic detailing appointment, or more information about the available CE topics, please email illinoisadvance@uic.edu.
For general information about the CE post-test and activity evaluation or CE credit information, please email pharmce@uic.edu.
Copyright © 2024– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy